We deliver integrated GMP-compliant design and engineering solutions dedicated to full-scale biosimilar manufacturing plants, covering monoclonal antibodies, fusion proteins, recombinant peptides and other complex biologic products. All design and engineering implementations strictly conform to FDA cGMP, EMA similarity evaluation guidelines, EU GMP and ISO biomanufacturing standards. Adopting the Quality by Design (QbD) framework, we embed biosimilar consistency evaluation criteria, process reproducibility and strict contamination control into overall plant engineering, delivering audit-ready manufacturing facilities that support stable batch production and global regulatory filing.
Our core design and engineering system targets the unique high-precision and low-variability requirements of biosimilar production. We implement scientific functional zoning for cell bank preservation, upstream cell culture and fermentation, downstream purification, sterile formulation and filling, and independent QC testing areas. Hierarchical ISO 5 to ISO 8 cleanroom classification, directional pressure gradient control and isolated personnel and material flow systems effectively eliminate cross-contamination and exogenous pollution. Customized HVAC, purified water, process gas and waste treatment utility systems maintain ultra-stable production environments, ensuring consistent product purity, structural similarity and batch-to-batch uniformity.
Covering full-lifecycle project engineering services, our scope includes pre-project feasibility study, process-oriented plant layout optimization, GMP facility schematic and construction design, cleanroom system engineering, complete MEP and utility system integration, modular construction deployment, system commissioning and qualification validation. We refine equipment layout, pipeline routing and operational workflows to adapt to closed-loop bioproduction processes, minimizing human intervention and process deviation. All engineering details comply with global biosimilar certification standards, supporting seamless process scale-up and standardized industrial production.
Backed by extensive biosimilar engineering practice and cross-standard compliance experience, our integrated design and engineering solutions balance regulatory compliance, operational efficiency and long-term scalability. Standardized engineering management avoids design defects and construction rework, greatly shortening project delivery and market launch cycles. Flexible modular layout and reserved intelligent upgrade interfaces accommodate future product pipeline expansion and process optimization. We help biopharmaceutical enterprises build cost-effective, fully compliant and globally certifiable biosimilar manufacturing bases to strengthen core competitiveness in the international biosimilar market.
